Susquehanna International Group, LLP Sana Biotechnology, Inc. Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.76 - $6.86 $441,424 - $805,364	117,400 Added 52.04%	343,000 $1.43 Million
Q2 2024 Aug 15, 2024	BUY	$5.23 - $10.44 $39,748 - $79,344	7,600 Added 3.49%	225,600 $1.23 Million
Q1 2024 May 07, 2024	BUY	$4.2 - $11.27 $816,900 - $2.19 Million	194,500 Added 827.66%	218,000 $2.18 Million
Q4 2023 Feb 14, 2024	BUY	$2.8 - $4.55 $22,680 - $36,855	8,100 Added 52.6%	23,500 $95,000
Q3 2023 Nov 14, 2023	SELL	$3.77 - $6.23 $1.48 Million - $2.45 Million	-392,800 Reduced 96.23%	15,400 $59,000
Q2 2023 Aug 11, 2023	BUY	$3.22 - $7.53 $1.31 Million - $3.07 Million	408,200 New	408,200 $2.43 Million
Q2 2022 Aug 15, 2022	SELL	$4.12 - $9.35 $25,544 - $57,970	-6,200 Reduced 37.58%	10,300 $66,000
Q1 2022 May 16, 2022	BUY	$5.24 - $15.58 $27,248 - $81,016	5,200 Added 46.02%	16,500 $136,000
Q4 2021 Feb 14, 2022	BUY	$15.18 - $23.15 $171,534 - $261,594	11,300 New	11,300 $175,000

174

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $447M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.